-
1
المؤلفون: Tomislav Dragovich, Ramez Awad, Naveen Yarlagadda, Mark Gimbel, Sunilkumar Kakadia, Madappa N. Kundranda, Jiaxin Niu, Lida A. Mina, Fade Mahmoud, Boris G. Naraev
المصدر: OncoTargets and therapy
مصطلحات موضوعية: BRAF inhibitor, 0301 basic medicine, endocrine system diseases, malignant melanoma, Review, resistance, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Encorafenib, medicine, Pharmacology (medical), skin and connective tissue diseases, Vemurafenib, neoplasms, Trametinib, Cobimetinib, MEK inhibitor, business.industry, Melanoma, Binimetinib, Dabrafenib, targeted therapy, medicine.disease, digestive system diseases, enzymes and coenzymes (carbohydrates), 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Cancer research, business, medicine.drug